Save this page
Save this page

My Saved Pages

  • Saved page.

My Saved Courses

  • Saved page.
Reset

Recently visited

  • Saved page.

Dr Geoffrey Coxon

Lecturer

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

Dr Geoff Coxon is a lecturer in Medicinal Chemistry. After receiving his PhD from the University of Newcastle upon Tyne, and a short term industry, he moved SIPBS where he set up his research group in the discovery and development of new agents to treat tuberculosis. He is the co-founder and Deputy Leader of TB Drug Discovery UK (www.tbd-uk.org.uk). In this role he works with fellow scientists and clinicians, UK government policy makers and advocates with the goal of strengthening scientific research across all areas of TB drug development as a key part of the UK response in the global eradiation of the disease.

The links here take you to the TBD-UK profile  page of Dr Geoff Coxon and the TBD-UK website home page

Publications

Characterisation of triterpenes and new phenolic lipids in Cameroonian propolis
Kardar M. N., Zhang T., Coxon G. D., Watson D. G., Fearnley J., Seidel V.
Phytochemistry Vol 106, pp. 156-163, (2014)
http://dx.doi.org/10.1016/j.phytochem.2014.07.016
Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues
Coxon Geoffrey, Craig Derek, Corrales Rosa Milagros, Vialla Emilie, Gannoun-Zaki Laila, Kremer Laurent
PLoS One Vol 8, pp. 1-13, (2013)
http://dx.doi.org/10.1371/journal.pone.0053162
Strategies and challenges involved in the discovery of new chemical entities during early-stage tuberculosis drug discovery
Coxon Geoffrey, Cooper Christopher B., Gillespie Stephen H., McHugh Timothy D.
Journal of Infectious Diseases, (2012)
http://dx.doi.org/10.1093/infdis/jis191
Synthesis of cis,cis-diunsaturated α-meromycolic acid by a palladium-catalysed alkyl–alkyl Negishi reaction
Berretta Giacomo, Coxon Geoffrey
Tetrahedron Letters Vol 53, pp. 214-216, (2012)
http://dx.doi.org/10.1016/j.tetlet.2011.11.021
Strategies and challenges involved in the discovry of new chemical entities during early-stage tuberculosis drug discovery
Coxon Geoffrey
Tuberculosis: Local and global, (2012)
Currrent status and research strategies in tuberculosis drug development
Dover Lynn G., Coxon Geoffrey
Journal of Medicinal Chemistry Vol 54, pp. 6157–6165, (2011)
http://dx.doi.org/10.1021/jm200305q

more publications

Professional activities

Gordon Research conference on TB Drug Development
Keynote/plenary speaker
8/2009
International Symposium on Tuberculosis , India
Keynote/plenary speaker
1/2008

more professional activities

Projects

Thiolactomycin and related inhibitors targeting fatty acid elongase enzymes in Mycobacterium tuberculosis
MacKay, Simon (Principal Investigator) Coxon, Geoffrey (Co-investigator) Johnston, Blair (Co-investigator)
Period 01-May-2005 - 30-Apr-2008
TB Drug Development-UK (TBD-UK)
Coxon, Geoffrey (Principal Investigator)
Period 20-Jul-2009 - 30-Apr-2012

more projects

Address

Strathclyde Institute of Pharmacy and Biomedical Sciences
John Arbuthnott Building Robertson Wing

Location Map

View University of Strathclyde in a larger map